Back to top
more

Johnson & Johnson (JNJ)

(Real Time Quote from BATS)

$146.78 USD

146.78
2,332,677

-1.75 (-1.18%)

Updated Apr 25, 2024 11:36 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 16% (211 out of 251)

Industry: Large Cap Pharmaceuticals

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Income Statements

Research for JNJ

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year end for Johnson & Johnson falls in the month of December .

All items in Millions except EPS data.

12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
Sales 85,159 94,943 93,775 82,584 82,059
Cost Of Goods 26,553 31,089 29,855 28,427 27,556
Gross Profit 58,606 63,854 63,920 54,157 54,503
Selling & Adminstrative & Depr. & Amort Expenses 45,294 42,833 41,067 37,681 37,571
Income After Depreciation & Amortization 13,312 21,021 22,853 16,476 16,932
Non-Operating Income 0 0 0 0 0
Interest Expense 772 276 183 201 318
Pretax Income 15,062 21,725 22,776 16,497 17,328
Income Taxes 1,736 3,784 1,898 1,783 2,209
Minority Interest 0 0 0 0 0
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 0 0 0 0 0
Income From Cont. Operations 13,326 17,941 20,878 14,714 15,119
Extras & Discontinued Operations 21,827 0 0 0 0
Net Income (GAAP) 35,153 17,941 20,878 14,714 15,119
Depreciation Footnote 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
Income Before Depreciation & Amortization 20,798 27,991 30,243 23,707 23,941
Depreciation & Amortization (Cash Flow) 7,486 6,970 7,390 7,231 7,009
Income After Depreciation & Amortization 13,312 21,021 22,853 16,476 16,932
Earnings Per Share Data 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
Average Shares 2,560.40 2,663.90 2,674.00 2,670.70 2,684.30
Diluted EPS Before Non-Recurring Items 9.92 10.15 9.80 8.03 8.68
Diluted Net EPS (GAAP) 13.72 6.73 7.81 5.51 5.63

Fiscal Year end for Johnson & Johnson falls in the month of December .

All items in Millions except EPS data.

3/31/24 12/31/23 9/30/23 6/30/23 3/31/23
Sales 21,383.00 13,532.00 21,351.00 25,530.00 24,746.00
Cost Of Goods 6,511.00 3,340.00 6,606.00 8,212.00 8,395.00
Gross Profit 14,872.00 10,192.00 14,745.00 17,318.00 16,351.00
SG&A, R&D, and Dept/Amort Expenses 8,850.00 6,919.00 10,084.00 10,948.00 17,343.00
Income After SG&A, R&D, and Dept/Amort Expenses 6,022.00 3,273.00 4,661.00 6,370.00 -992.00
Non-Operating Income NA 0.00 0.00 0.00 0.00
Interest Expense NA 19.00 192.00 346.00 215.00
Pretax Income 6,440.00 3,820.00 5,217.00 6,762.00 -737.00
Income Taxes 1,086.00 -121.00 908.00 1,618.00 -669.00
Minority Interest NA 0.00 0.00 0.00 0.00
Investment Gains/Losses NA 0.00 0.00 0.00 0.00
Other Income/Charges NA 0.00 0.00 0.00 0.00
Income From Cont. Operations 5,354.00 3,941.00 4,309.00 5,144.00 -68.00
Extras & Discontinued Operations 0.00 108.00 21,719.00 0.00 0.00
Net Income (GAAP) 5,354.00 4,049.00 26,028.00 5,144.00 -68.00
Earnings Per Share Data 3/31/24 12/31/23 9/30/23 6/30/23 3/31/23
Average Shares 2,430.10 2,430.70 2,549.70 2,625.70 2,605.50
Diluted EPS Before Non-Recurring Items 2.71 2.29 2.66 2.80 2.68
Diluted Net EPS (GAAP) 2.20 1.58 10.21 1.96 -0.03